These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9425261)

  • 41. Analysis of the relationship between PPAR-gamma 2 gene variants and severe insulin resistance in obese patients with impaired glucose tolerance.
    Blüher M; Paschke R
    Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):85-90. PubMed ID: 12746759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects.
    Mirzaei H; Akrami SM; Golmohammadi T; Doosti M; Heshmat R; Nakhjavani M; Amiri P
    Metab Syndr Relat Disord; 2009 Oct; 7(5):453-8. PubMed ID: 19558269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population.
    Zhou TB; Guo XF; Yin SS
    J Recept Signal Transduct Res; 2014 Jun; 34(3):180-4. PubMed ID: 24329532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity.
    Celi FS; Shuldiner AR
    Curr Diab Rep; 2002 Apr; 2(2):179-85. PubMed ID: 12643137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.
    Stumvoll M; Häring H
    Diabetes; 2002 Aug; 51(8):2341-7. PubMed ID: 12145143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects.
    Park KS; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Nikoulina SE; Henry RR
    Diabetes; 1997 Jul; 46(7):1230-4. PubMed ID: 9200661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients.
    Auboeuf D; Rieusset J; Fajas L; Vallier P; Frering V; Riou JP; Staels B; Auwerx J; Laville M; Vidal H
    Diabetes; 1997 Aug; 46(8):1319-27. PubMed ID: 9231657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Pro-115 --> Gln mutation in peroxisome-proliferator-activated receptor (PPAR) gamma2 is extremely rare in a large cohort of U.S. Caucasians.
    Terrett J; Chamberlain J; Rastan S; Marshall R; McGinnis R; Spurr N; O'Brien E; Evans C; Rut A
    Clin Sci (Lond); 2000 Jul; 99(1):89-90. PubMed ID: 10887062
    [No Abstract]   [Full Text] [Related]  

  • 49. Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma2 (PPARgamma2) and severe obesity: a case-control study.
    Vaccaro O; Mancini FP; Ruffa G; Sabatino L; Colantuoni V; Riccardi G
    Int J Obes Relat Metab Disord; 2000 Sep; 24(9):1195-9. PubMed ID: 11033990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus.
    Simón I; Vendrell J; Gutiérrez C; Fernández-Real JM; Vendrell I; Gallart L; Fontova R; Richart C
    Horm Res; 2002; 58(3):143-9. PubMed ID: 12218380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphisms of the peroxisome proliferator-activated receptor-γ (rs1801282) and its coactivator-1 (rs8192673) are associated with obesity indexes in subjects with type 2 diabetes mellitus.
    Kruzliak P; Haley AP; Starcevic JN; Gaspar L; Petrovic D
    Cardiovasc Diabetol; 2015 Apr; 14():42. PubMed ID: 25928419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome.
    Dongxia L; Qi H; Lisong L; Jincheng G
    Circ J; 2008 Apr; 72(4):551-7. PubMed ID: 18362424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The difference of mutation in the peroxisome proliferator activated receptor gamma2 gene among people at high altitudes and low altitudes in Bolivia.
    Karasaki Y; Kashiwazaki H
    J UOEH; 2005 Sep; 27(3):243-8. PubMed ID: 16180511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.
    González Sánchez JL; Serrano Ríos M; Fernández Perez C; Laakso M; Martínez Larrad MT
    Eur J Endocrinol; 2002 Oct; 147(4):495-501. PubMed ID: 12370112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Mexican Americans with Type 2 diabetes mellitus.
    Celi FS; Negri C; Tanner K; Raben N; De Pablo F; Rovira A; Pallardo LF; Martin-Vaquero P; Stern MP; Mitchell BD; Shuldiner AR
    Diabetes Metab Res Rev; 2000; 16(5):370-7. PubMed ID: 11025561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Pro12Ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men.
    Rosmond R; Chagnon M; Bouchard C
    Diabetes Metab Res Rev; 2003; 19(2):159-63. PubMed ID: 12673785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men.
    Ek J; Urhammer SA; Sørensen TI; Andersen T; Auwerx J; Pedersen O
    Diabetologia; 1999 Jul; 42(7):892-5. PubMed ID: 10440134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects.
    Hamann A; Münzberg H; Buttron P; Büsing B; Hinney A; Mayer H; Siegfried W; Hebebrand J; Greten H
    Eur J Endocrinol; 1999 Jul; 141(1):90-2. PubMed ID: 10407229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients.
    Zouari Bouassida K; Chouchane L; Jellouli K; Chérif S; Haddad S; Gabbouj S; Danguir J
    Diabetes Metab; 2005 Apr; 31(2):119-23. PubMed ID: 15959417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth.
    Eriksson JG; Lindi V; Uusitupa M; Forsén TJ; Laakso M; Osmond C; Barker DJ
    Diabetes; 2002 Jul; 51(7):2321-4. PubMed ID: 12086968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.